DocGo Inc. Noncontrolling Interest, Increase from Subsidiary Equity Issuance
DocGo Inc. (DCGO) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $2.06 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2025-02-27
- DocGo Inc. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2022-03-31 was $2.06M.
- DocGo Inc. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2022 was $2.06M, a 519.47% increase from fiscal 2021.
- DocGo Inc. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2021 was $333.02K.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|
| 2022-12-31 | $2.06M 10-K · filed 2025-02-27 | |
| 2022-03-31 | $2.06M 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $333.02K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |